Acalculous Acute Pancreatitis in a COVID-19 Patient

Coronavirus disease 2019 (COVID-19) is a multisystemic condition caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with manifestations ranging from mild upper respiratory symptoms to cytokine storm causing acute respiratory distress syndrome. Pancreatic exocrine tissue and endoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Meireles, Pedro Antunes, Bessa, Filipe, Gaspar, Pedro, Parreira, Inês, Silva, Virgílio Dias, Mota, Catarina, Alvoeiro, Lourdes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SMC Media Srl 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279899/
https://www.ncbi.nlm.nih.gov/pubmed/32523925
http://dx.doi.org/10.12890/2020_001710
Descripción
Sumario:Coronavirus disease 2019 (COVID-19) is a multisystemic condition caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with manifestations ranging from mild upper respiratory symptoms to cytokine storm causing acute respiratory distress syndrome. Pancreatic exocrine tissue and endocrine islets both express angiotensin-converting enzyme 2 (ACE2), the proven receptor for SARS-CoV-2 cell internalization. An increase in pancreatic enzymes has been increasingly recognized in patients with COVID-19, but little is known about the real prevalence of acute pancreatitis in this population. We report a case of acute acalculous pancreatitis in a COVID-19 patient. LEARNING POINTS: Acute pancreatitis may be a manifestation of SARS-CoV-2 infection. Future studies must address the real impact of pancreatic involvement in COVID-19 patients.

Ejemplares similares